Publication | Closed Access

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults

Hypertensive AdultsNon-pharmacological InterventionHypertensionMedicineAntihypertensive TherapyValsartan/hydrochlorothiazide Combination TherapyLong-term Combination TherapyPharmacotherapyPharmacologyEndocrine Hypertension